AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. GNLX
  4. [ARS] Genelux Corporation SEC Filing

[ARS] Genelux Corporation SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
Rhea-AI Filing Summary
Riscrivi il testo seguente:
Reescribe el siguiente texto:
雼れ潓 韰嶌姢韸鸽ゼ 雼れ嫓 鞛戩劚頃橃劯鞖�:
R茅茅crivez le texte suivant :
Schreiben Sie den folgenden Text um:
Positive
  • None.
Negative
  • None.
Riscrivi il testo seguente:
Reescribe el siguiente texto:
雼れ潓 韰嶌姢韸鸽ゼ 雼れ嫓 鞛戩劚頃橃劯鞖�:
R茅茅crivez le texte suivant :
Schreiben Sie den folgenden Text um:
ARS - Genelux Corporation

AG真人官方

ARS Filing - Genelux Corporation

This filing is available as a PDF document.

Filing Type: ARS

Company: Genelux Corporation (GNLX)

Acceptance Date: 2025-07-11T08:10:38.000Z

Source:

Stock GNLX logo
Genelux Corp

NASDAQ:GNLX

GNLX Rankings

#6373 Ranked by Market Cap
N/A Ranked by Dividends

GNLX Latest News

Aug 7, 2025
Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates
Jul 7, 2025
Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development
May 6, 2025
Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates
May 1, 2025
Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference
Mar 28, 2025
Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

GNLX Latest SEC Filings

Aug 7, 2025
[S-8] Genelux Corporation Employee Benefit Plan Registration
Jul 25, 2025
[SCHEDULE 13G/A] Genelux Corporation SEC Filing
Jul 11, 2025
[DEFA14A] Genelux Corporation Additional Proxy Soliciting Materials
Jul 11, 2025
[DEF 14A] Genelux Corporation Definitive Proxy Statement
Jul 2, 2025
[Form 4] Genelux Corporation Insider Trading Activity

GNLX Stock Data

133.30M
33.45M
11.41%
20.06%
6.13%
Biotechnology
Pharmaceutical Preparations
United States
WESTLAKE VILLAGE